Deregulated Expression of miR-224 and its Target Gene: CD59 Predicts Outcome of Diffuse Large B-cell Lymphoma Patients Treated with R-CHOP
Journal:
Current Cancer Drug Targets
Volume:
14
Page:
659-670
Author(s):
Guoqi Song, Guorong Song, Huiyun Ni, Ling Gu, Hong Liu, Baoan Chen, Bangshun He, Yuqin Pan, Shukui Wang and William C. Cho
Na+/K+ ATPase Inhibitors in Cancer
Journal:
Current Drug Targets
Volume:
15
Page:
988-1000
Author(s):
Konstantinos Alevizopoulos, Theodora Calogeropoulou, Florian Lang and Christos Stournaras
Targeting miRNAs for Pancreatic Cancer Therapy
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
5279-5286
Author(s):
Min Shi, DachengXie, Yong Gaod and Keping Xie
MicroRNAs and Cancer; an Overview
Journal:
Current Pharmaceutical Biotechnology
Volume:
15
Page:
430-437
Author(s):
Lutfi Tutar, Esen Tutar and Yusuf Tutar
MicroRNA-Mediated Cancer Metastasis Regulation via Heterotypic Signals in the Microenvironment
Journal:
Current Pharmaceutical Biotechnology
Volume:
15
Page:
455-458
Author(s):
Haizhong Ma, Chunli Liang, Guangxue Wang, Sujuan Jia, Qian Zhao, Zhendong Xiang, Yuan Li, William C. Cho, Richard G. Pestell, Li Liang and Zuoren Yu
Nanoparticulate Drug Delivery Systems for Treatment of Hepatocellular Carcinoma
Journal:
Current Cancer Therapy Reviews
Volume:
10
Page:
22-33
Author(s):
Shruti S. Shrikhande, Darshana S. Jain, Rajani B. Athawale and Amrita N. Bajaj
Nanoparticulate Drug Delivery System to Overcome the Limitations of Conventional Curcumin in the Treatment of Various Cancers: A Review
Journal:
Drug Delivery Letters
Volume:
4
Page:
116-127
Author(s):
Moorthi Chidambaram and Kathiresan Krishnasamy
High-density Lipoprotein, Vascular Risk, Cancer and Infection: A Case of Quantity and Quality?
Journal:
Current Medicinal Chemistry
Volume:
21
Page:
2917-2926
Author(s):
N. Katsiki, V.G. Athyros, A. Karagiannis and D.P. Mikhailidis
Prognostic and Predictive Biomarkers in Cancer
Journal:
Current Cancer Drug Targets
Volume:
14
Page:
477-504
Author(s):
Meera Nair, Sardul Singh Sandhu and Anil K. Sharma
PARP Inhibitors: An Interesting Pathway also for Non-Small Cell Lung Cancer?
Journal:
Current Pharmaceutical Design
Volume:
20
Page:
3875-3882
Author(s):
Matteo Giaj Levra, Ken Andre Olaussen, Silvia Novello and Jean-Charles Soria